<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39590834</PMID><DateRevised><Year>2024</Year><Month>11</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2218-1989</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>07</Day></PubDate></JournalIssue><Title>Metabolites</Title><ISOAbbreviation>Metabolites</ISOAbbreviation></Journal><ArticleTitle>Salivary Metabolomics in Patients with Long COVID-19 Infection.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">598</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/metabo14110598</ELocationID><Abstract><AbstractText><b>Background:</b> Long COVID-19 has been characterized by the presence of symptoms lasting longer than 4 weeks after the acute infection. The pathophysiology of clinical manifestations still lacks knowledge. <b>Objective:</b> The objective of this paper was to evaluate metabolite abundance in the saliva of long COVID patients 60 days after hospital discharge. <b>Methods:</b> A convenience sample was composed of 30 post-discharge patients with long COVID and seven non-COVID-19 controls. All COVID-19 patients were evaluated by demographic characteristics, spirometry, 6 min walk test (6mWT), Saint George Respiratory Questionnaire (SGRQ), and body composition. Metabolomics was performed on saliva. <b>Results:</b> The long COVID-19 patients were 60.4 &#xb1; 14.3 years-old, and 66% male. Their lean body mass was 30.7 &#xb1; 7.3 kg and fat mass, 34.4 &#xb1; 13.7 kg. Spirometry evaluation showed forced vital capacity (FVC) of 3.84 &#xb1; 0.97 L with 96.0 &#xb1; 14.0% of the predicted value, and forced expiratory volume in the first second (FEV<sub>1</sub>) of 3.11 &#xb1; 0.83 L with 98.0 &#xb1; 16.0 of the predicted value. The long COVID-19 patients had reduced maximal inspiratory (90.1 &#xb1; 31.6 cmH<sub>2</sub>O) and maximal expiratory (97.3 &#xb1; 31.0 cmH<sub>2</sub>O) pressures. SGRQ showed domain symptoms of 32.3 &#xb1; 15.2, domain activities of 41.9 &#xb1; 25.6, and domain impact 13.7 &#xb1; 11.4, with a mean of 24.3 &#xb1; 14.9%. Physical capacity measured by distance covered in the 6mWT was 418.2 &#xb1; 130 m with a 73.3% (22.3-98.1) predictive value. The control group consisted of 44.1 &#xb1; 10.7-year-old men with a body mass index of 26.5 &#xb1; 1.66 Kg/m<sup>2</sup>. Metabolomics revealed 19 differentially expressed metabolites; expression was lower in 16 metabolites, and 2 metabolites were absent in the COVID-19 patients compared to controls. Calenduloside G methyl ester (<i>p</i> = 0.03), Gly Pro Lys (<i>p</i> = 0.0001), and creatine (<i>p</i> = 0.0001) expressions were lower in patients than controls. <b>Conclusions:</b> Long COVID-19 patients present less abundance of calenduloside G methyl ester, Gly Pro Lys, and creatine in saliva than healthy controls. Lower creatine abundance may be related to reduced physical capacity and fatigue.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Machado</LastName><ForeName>Luiz</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-1975-879X</Identifier><AffiliationInfo><Affiliation>Botucatu Medical School, S&#xe3;o Paulo State University, Botucatu 18618-970, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prudente</LastName><ForeName>Robson</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-1175-1435</Identifier><AffiliationInfo><Affiliation>Botucatu Medical School, S&#xe3;o Paulo State University, Botucatu 18618-970, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franco</LastName><ForeName>Estef&#xe2;nia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Botucatu Medical School, S&#xe3;o Paulo State University, Botucatu 18618-970, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gatto</LastName><ForeName>Mariana</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3115-0795</Identifier><AffiliationInfo><Affiliation>Botucatu Medical School, S&#xe3;o Paulo State University, Botucatu 18618-970, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mota</LastName><ForeName>Gustavo</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-8103-3338</Identifier><AffiliationInfo><Affiliation>Botucatu Medical School, S&#xe3;o Paulo State University, Botucatu 18618-970, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pagan</LastName><ForeName>Luana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Botucatu Medical School, S&#xe3;o Paulo State University, Botucatu 18618-970, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brizola</LastName><ForeName>Lu&#xed;s</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Botucatu Medical School, S&#xe3;o Paulo State University, Botucatu 18618-970, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dos Santos</LastName><ForeName>Ma&#xe9;rcio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Botucatu Medical School, S&#xe3;o Paulo State University, Botucatu 18618-970, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cunha</LastName><ForeName>Thulio</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Faculty of Medicine of the Federal, University of Uberlandia, Uberl&#xe2;ndia 38408-100, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabino-Silva</LastName><ForeName>Robinson</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Faculty of Medicine of the Federal, University of Uberlandia, Uberl&#xe2;ndia 38408-100, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goulart</LastName><ForeName>Luiz</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-1803-4861</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine of the Federal, University of Uberlandia, Uberl&#xe2;ndia 38408-100, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>Mario</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7381-2788</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine of the Federal, University of Uberlandia, Uberl&#xe2;ndia 38408-100, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>Paula</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-2650-6635</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine of the Federal, University of Uberlandia, Uberl&#xe2;ndia 38408-100, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maia</LastName><ForeName>Larissa</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-7283-1020</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine of the Federal, University of Uberlandia, Uberl&#xe2;ndia 38408-100, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albuquerque</LastName><ForeName>Andr&#xe9;</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pneumology, University of S&#xe3;o Paulo, S&#xe3;o Paulo 05403-000, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferreira</LastName><ForeName>Eloara</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-3291-6473</Identifier><AffiliationInfo><Affiliation>Department of the Federal, University of S&#xe3;o Paulo, S&#xe3;o Paulo 01246-903, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baldi</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-9609-5117</Identifier><AffiliationInfo><Affiliation>Department of Pneumology, University of S&#xe3;o Paulo, S&#xe3;o Paulo 05403-000, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okoshi</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Botucatu Medical School, S&#xe3;o Paulo State University, Botucatu 18618-970, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanni</LastName><ForeName>Suzana</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-2587-2759</Identifier><AffiliationInfo><Affiliation>Botucatu Medical School, S&#xe3;o Paulo State University, Botucatu 18618-970, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Metabolites</MedlineTA><NlmUniqueID>101578790</NlmUniqueID><ISSNLinking>2218-1989</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">functional capacity</Keyword><Keyword MajorTopicYN="N">metabolomics</Keyword><Keyword MajorTopicYN="N">post-COVID-19</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>26</Day><Hour>18</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>26</Day><Hour>18</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>26</Day><Hour>13</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39590834</ArticleId><ArticleId IdType="pmc">PMC11596941</ArticleId><ArticleId IdType="doi">10.3390/metabo14110598</ArticleId><ArticleId IdType="pii">metabo14110598</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization  WHO Coronavirus Disease (COVID-19) Dashboard.  [(accessed on 18 April 2024)].  Available online:  https://covid19.who.int/</Citation></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Gameros C.A., Colin-Mart&#xed;nez T., Waizel-Haiat S., Vargas-Ortega G., Ferat-Osorio E., Guerrero-Paz J.A., Intriago-Alor M., L&#xf3;pez-Moreno M.A., Cuevas-Garc&#xed;a C.F., Mendoza-Zubieta V., et al. Diagnostic accuracy of symptoms as a diagnostic tool for SARS-CoV-2 infection: A cross-sectional study in a cohort of 2173 patients. BMC Infect. Dis. 2021;21:255. doi: 10.1186/s12879-021-05930-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-05930-1</ArticleId><ArticleId IdType="pmc">PMC7947944</ArticleId><ArticleId IdType="pubmed">33706707</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakodkar P., Kaka N., Baig M. A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19) Cureus. 2020;12:e7560. doi: 10.7759/cureus.7560.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.7560</ArticleId><ArticleId IdType="pmc">PMC7138423</ArticleId><ArticleId IdType="pubmed">32269893</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonnet A., Chetboun M., Poissy J., Raverdy V., Noulette J., Duhamel A., Labreuche J., Mathieu D., Pattou F., Jourdain M., et al. High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity. 2020;28:1195&#x2013;1199. doi: 10.1002/oby.22831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/oby.22831</ArticleId><ArticleId IdType="pmc">PMC7262326</ArticleId><ArticleId IdType="pubmed">32271993</ArticleId></ArticleIdList></Reference><Reference><Citation>Palaiodimos L., Kokkinidis D.G., Li W., Karamanis D., Ognibene J., Arora S., Southern W.N., Mantzoros C.S. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism. 2020;108:154262. doi: 10.1016/j.metabol.2020.154262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2020.154262</ArticleId><ArticleId IdType="pmc">PMC7228874</ArticleId><ArticleId IdType="pubmed">32422233</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranzani O.T., Bastos L.S.L., Gelli J.G.M., Marchesi J.F., Bai&#xe3;o F., Hamacher S., Bozza F.A. Characterisation of the first 250,000 hospital admissions for COVID-19 in Brazil: A retrospective analysis of nationwide data. Lancet Respir. Med. 2021;9:407&#x2013;418. doi: 10.1016/S2213-2600(20)30560-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30560-9</ArticleId><ArticleId IdType="pmc">PMC7834889</ArticleId><ArticleId IdType="pubmed">33460571</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersinga W.J., Rhodes A., Cheng A.C., Peacock S.J., Prescott H.C. Fisiopatologia, transmiss&#xe3;o, diagn&#xf3;stico e tratamento da doen&#xe7;a do coronav&#xed;rus 2019 (COVID-19): Uma revis&#xe3;o. JAMA. 2020;324:782&#x2013;793. doi: 10.1001/jama.2020.12839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12839</ArticleId><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanni S.E., Fabro A.T., de Albuquerque A., Ferreira E.V.M., Verrastro C.G.Y., Sawamura M.V.Y., Ribeiro S.M., Baldi B.G. Pulmonary fibrosis secondary to COVID-19: A narrative review. Expert Rev. Respir. Med. 2021;15:791&#x2013;803. doi: 10.1080/17476348.2021.1916472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17476348.2021.1916472</ArticleId><ArticleId IdType="pubmed">33902377</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanni S.E., Tonon C.R., Gatto M., Mota G.A.F., Okoshi M.P. Post-COVID-19 syndrome: Cardiovascular manifestations. Int. J. Cardiol. 2022;369:80&#x2013;81. doi: 10.1016/j.ijcard.2022.08.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2022.08.054</ArticleId><ArticleId IdType="pmc">PMC9434909</ArticleId><ArticleId IdType="pubmed">36058345</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. National Institute for Health and Care Excellence; London, UK: 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Levison M.E. Commentary: What We Know So Far About Post-COVID Syndrome. Merck Manual Consumer Version; Rahway, NJ, USA: 2020.</Citation></Reference><Reference><Citation>Carfi A., Bernabei R., Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Knight M., A&#x2019;Court C., Buxton M., Husain L. Management of post-acute COVID-19 in primary care. BMJ. 2020;370:m3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V., Flanders S.A., O&#x2019;Malley M., Malani A.N., Prescott H.C. Sixty-Day Outcomes among Patients Hospitalized with COVID-19. Ann. Intern. Med. 2021;174:576&#x2013;578. doi: 10.7326/M20-5661.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5661</ArticleId><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Kojima N., Turner F., Slepnev V., Bacelar A., Deming L., Kodeboyina S., Klausner J.D. Self-Collected Oral Fluid and Nasal Swabs Demonstrate Comparable Sensitivity to Clinician-Collected Nasopharyngeal Swabs for Coronavirus Disease 2019 Detection. Clin. Infect. Dis. 2021;73:e3106&#x2013;e3109. doi: 10.1093/cid/ciaa1589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1589</ArticleId><ArticleId IdType="pmc">PMC7665422</ArticleId><ArticleId IdType="pubmed">33075138</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapkota D., Soland T.M., Galtung H.K., Sand L.P., Giannecchini S., To K.K.W., Mendes-Correa M.C., Giglio D., Hass&#xe9;us B., Braz-Silva P.H. COVID-19 salivary signature: Diagnostic and research opportunities. J. Clin. Pathol. 2020;74:344&#x2013;349. doi: 10.1136/jclinpath-2020-206834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jclinpath-2020-206834</ArticleId><ArticleId IdType="pubmed">32769214</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaczor-Urbanowicz K.E., Martin Carreras-Presas C., Aro K., Tu M., Garcia-Godoy F., Wong D.T. Saliva diagnostics&#x2014;Current views and directions. Exp. Biol. Med. 2017;242:459&#x2013;472. doi: 10.1177/1535370216681550.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1535370216681550</ArticleId><ArticleId IdType="pmc">PMC5367650</ArticleId><ArticleId IdType="pubmed">27903834</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C.Z., Cheng X.Q., Li J.Y., Zhang P., Yi P., Xu X., Zhou X.D. Saliva in the diagnosis of diseases. Int. J. Oral Sci. 2016;8:133&#x2013;137. doi: 10.1038/ijos.2016.38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ijos.2016.38</ArticleId><ArticleId IdType="pmc">PMC5113094</ArticleId><ArticleId IdType="pubmed">27585820</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro T., Sabalza M., Barber C., Abrams W., Da Costa A.C., Milagres F.A.D.P., Braz-Silva P.H., Malamud D., Gallottini M. Rapid diagnosis of Zika virus through saliva and urine by Loop-mediated isothermal amplification (LAMP) J. Oral Microbiol. 2018;10:1510712. doi: 10.1080/20002297.2018.1510712.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20002297.2018.1510712</ArticleId><ArticleId IdType="pmc">PMC6127837</ArticleId><ArticleId IdType="pubmed">30202506</ArticleId></ArticleIdList></Reference><Reference><Citation>Braz-Silva P.H., Pallos D., Giannecchini S., To K.K. SARS-CoV-2: What can saliva tell us? Oral Dis. 2020;27:746&#x2013;747. doi: 10.1111/odi.13365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/odi.13365</ArticleId><ArticleId IdType="pmc">PMC7264628</ArticleId><ArticleId IdType="pubmed">32311181</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Zhao J., Peng J., Li X., Deng X., Geng Z., Shen Z., Guo F., Zhang Q., Jin Y., et al. Detection of SARS-CoV-2 in saliva and characterization of oral symptoms in COVID-19 patients. Cell Prolif. 2020;53:e12923. doi: 10.1111/cpr.12923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cpr.12923</ArticleId><ArticleId IdType="pmc">PMC7645955</ArticleId><ArticleId IdType="pubmed">33073910</ArticleId></ArticleIdList></Reference><Reference><Citation>Mali S.N., Thorat B.R., Chopade A.R. A Viewpoint on angiotensin-converting enzyme 2, anti-hypertensives and Coronavirus Disease 2019 (COVID-19) Infect. Disord. Drug Targets. 2021;21:311&#x2013;313.</Citation><ArticleIdList><ArticleId IdType="pubmed">32389117</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Kr&#xfc;ger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271&#x2013;280. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellinghaus D., Degenhardt F., Bujanda L., Buti M., Albillos A., Invernizzi P., Fern&#xe1;ndez J., Prati D., Baselli G., Asselta R., et al. Genomewide Association Study of Severe Covid-19 with Respiratory Failure. N. Engl. J. Med. 2020;383:1522&#x2013;1534. doi: 10.1056/NEJMoa2020283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2020283</ArticleId><ArticleId IdType="pmc">PMC7315890</ArticleId><ArticleId IdType="pubmed">32558485</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulte-Schrepping J., Reusch N., Paclik D., Ba&#xdf;ler K., Schlickeiser S., Zhang B., Kr&#xe4;mer B., Krammer T., Brumhard S., Bonaguro L., et al. Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment. Cell. 2020;182:1419&#x2013;1440. doi: 10.1016/j.cell.2020.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.001</ArticleId><ArticleId IdType="pmc">PMC7405822</ArticleId><ArticleId IdType="pubmed">32810438</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvin A., Chapuis N., Dunsmore G., Goubet A.G., Dubuisson A., Derosa L., Almire C., H&#xe9;non C., Kosmider O., Droin N., et al. Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19. Cell. 2020;182:1401&#x2013;1418. doi: 10.1016/j.cell.2020.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.002</ArticleId><ArticleId IdType="pmc">PMC7405878</ArticleId><ArticleId IdType="pubmed">32810439</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen B., Yi X., Sun Y., Bi X., Du J., Zhang C., Quan S., Zhang F., Sun R., Qian L., et al. Proteomic and Metabolomic Characterization of COVID-19 Patient Sera. Cell. 2020;182:59&#x2013;72. doi: 10.1016/j.cell.2020.05.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.032</ArticleId><ArticleId IdType="pmc">PMC7254001</ArticleId><ArticleId IdType="pubmed">32492406</ArticleId></ArticleIdList></Reference><Reference><Citation>Sousa T.C., Jardim J.R., Jones P. Validation of the Saint George Respiratory Questionnaire (SGRQ) in patients with chronic obstructive disease in Brazil. J. Bras. Pneumol. 2000;26:119&#x2013;125. doi: 10.1590/S0102-35862000000300004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0102-35862000000300004</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovelis D., Segretti N.O., Probst V.S., Lareau S.C., Brunetto A.F., Pitta F. Validation of the Modified Pulmonary Functional Status and Dyspnea Questionnaire and the Medical Research Council scale for use in Brazilian patients with chronic obstructive pulmonary disease. J. Bras. Pneumol. 2008;34:1008&#x2013;1018. doi: 10.1590/S1806-37132008001200005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S1806-37132008001200005</ArticleId><ArticleId IdType="pubmed">19180335</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixeira C.A., Santos J.E., Silva G.A., Souza E.S.T., Martinez J.A.B. Dispneia: Novos conhecimentos sobre um velho problema. J. Bras. Pneumol. 2007;33:28&#x2013;35. doi: 10.1590/S1806-37132007000100008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S1806-37132007000100008</ArticleId><ArticleId IdType="pubmed">17568865</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller M.R., Hankinson J., Brusasco F., Burgos R., Casaburi R., Coates R., Crapo R., Enright C.P.M., van der Grinten P., Gustafsson R., et al. General considerations for lung function testing. Eur. Respir. J. 2005;26:153&#x2013;161. doi: 10.1183/09031936.05.00034505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.05.00034505</ArticleId><ArticleId IdType="pubmed">15994402</ArticleId></ArticleIdList></Reference><Reference><Citation>ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories ATS statement: Guidelines for the six-minute walk test. Am. J. Respir. Crit. Care Med. 2002;166:111&#x2013;117. doi: 10.1164/ajrccm.166.1.at1102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.166.1.at1102</ArticleId><ArticleId IdType="pubmed">12091180</ArticleId></ArticleIdList></Reference><Reference><Citation>Borg G. Escalas de Borg Para Dor E Esfor&#xe7;o Percebido. Manole; S&#xe3;o Paulo, Brazil: 2000. Escala CR10 de Borg; pp. 43&#x2013;47.</Citation></Reference><Reference><Citation>Geretti A.M., Stockdale A.J., Kelly S.H., Cevik M., Collins S., Waters L., Villa G., Docherty A., Harrison E.M., Turtle L., et al. Outcomes of Coronavirus Disease 2019 (COVID-19) Related Hospitalization Among People with Human Immunodeficiency Virus (HIV) in the ISARIC World Health Organization (WHO) Clinical Characterization Protocol (UK): A Prospective Observational Study. Clin. Infect. Dis. 2021;73:e2095&#x2013;e2106. doi: 10.1093/cid/ciaa1605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1605</ArticleId><ArticleId IdType="pmc">PMC7665382</ArticleId><ArticleId IdType="pubmed">33095853</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent J.L., Moreno R., Takala J., Willatts S., De Mendon&#xe7;a A., Bruining H., Reinhart C.K., Suter P.M., Thijs L.G. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med. 1996;22:707&#x2013;710. doi: 10.1007/BF01709751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01709751</ArticleId><ArticleId IdType="pubmed">8844239</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno R.P., Metnitz P.G., Almeida E., Jordan B., Bauer P., Campos R.A., Iapichino G., Edbrooke D., Capuzzo M., Le Gall J.R., et al. SAPS 3&#x2014;From evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med. 2005;31:1345&#x2013;1355. doi: 10.1007/s00134-005-2763-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-005-2763-5</ArticleId><ArticleId IdType="pmc">PMC1315315</ArticleId><ArticleId IdType="pubmed">16132892</ArticleId></ArticleIdList></Reference><Reference><Citation>Salluh J.I., Soares M. ICU severity of illness scores: APACHE, SAPS and MPM. Curr. Opin. Crit. Care. 2014;20:557&#x2013;565. doi: 10.1097/MCC.0000000000000135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCC.0000000000000135</ArticleId><ArticleId IdType="pubmed">25137401</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J., Liu Y., Chen C., Chen H., Huang J., Luo Y., Zhao K., Chen D., Xu Z., Li W., et al. Cyasterone accelerates fracture healing by promoting MSCs migration and osteogenesis. J. Orthop. Transl. 2021;28:28&#x2013;38. doi: 10.1016/j.jot.2020.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jot.2020.11.004</ArticleId><ArticleId IdType="pmc">PMC7905397</ArticleId><ArticleId IdType="pubmed">33717979</ArticleId></ArticleIdList></Reference><Reference><Citation>Petronelli A., Pannitteri G., Testa U. Triterpenoids as new promising anticancer drugs. Anti-Cancer Drugs. 2009;20:880&#x2013;892. doi: 10.1097/CAD.0b013e328330fd90.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CAD.0b013e328330fd90</ArticleId><ArticleId IdType="pubmed">19745720</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu S.Y., Oak M.H., Yoon S.K., Cho D.I., Yoo G.S., Kim T.S., Kim K.M. Anti-allergic and anti-inflammatory triterpenes from the herb of Prunella vulgaris. Planta Med. 2000;66:358&#x2013;360. doi: 10.1055/s-2000-8531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2000-8531</ArticleId><ArticleId IdType="pubmed">10865455</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaguchi Y., Yamada K., Yoshikawa N., Nakamura K., Haginaka J., Kunitomo M. Corosolic acid prevents oxidative stress, inflammation and hypertension in SHR/NDmcr-cp rats, a model of metabolic syndrome. Life Sci. 2006;79:2474&#x2013;2479. doi: 10.1016/j.lfs.2006.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2006.08.007</ArticleId><ArticleId IdType="pubmed">16959274</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee B., Lee D.Y., Yoo K.H., Baek N.I., Park J.H., Chung I.S. Calenduloside E 6&#x2032;-methyl ester induces apoptosis in CT-26 mouse colon carcinoma cells and inhibits tumor growth in a CT-26 xenograft animal model. Oncol. Lett. 2012;4:22&#x2013;28. doi: 10.3892/ol.2012.693.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ol.2012.693</ArticleId><ArticleId IdType="pmc">PMC3398352</ArticleId><ArticleId IdType="pubmed">22807953</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagadala N.S., Landi A., Maturu P., Tuszynski J. In silico identification of RBD subdomain of spike protein from Pro322-Thr581 for applications in vaccine development against SARS-CoV2. J. Mol. Struct. 2021;1240:130534. doi: 10.1016/j.molstruc.2021.130534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molstruc.2021.130534</ArticleId><ArticleId IdType="pmc">PMC8087216</ArticleId><ArticleId IdType="pubmed">33967342</ArticleId></ArticleIdList></Reference><Reference><Citation>Moneim A.A., Radwan M.A., Yousef A.I. COVID-19 and cardiovascular disease: Manifestations, pathophysiology, vaccination, and long-term implication. Curr. Med. Res. Opin. 2022;38:1071&#x2013;1079. doi: 10.1080/03007995.2022.2078081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03007995.2022.2078081</ArticleId><ArticleId IdType="pubmed">35575011</ArticleId></ArticleIdList></Reference><Reference><Citation>Franks A.H., Harmsen H.J., Raangs G.C., Jansen G.J., Schut F., Welling G.W. Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl. Environ. Microbiol. 1998;64:3336&#x2013;3345. doi: 10.1128/AEM.64.9.3336-3345.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.64.9.3336-3345.1998</ArticleId><ArticleId IdType="pmc">PMC106730</ArticleId><ArticleId IdType="pubmed">9726880</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson G.R., Roberfroid M.B. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J. Nutr. 1995;125:1401&#x2013;1412. doi: 10.1093/jn/125.6.1401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jn/125.6.1401</ArticleId><ArticleId IdType="pubmed">7782892</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung J.Y., Kim Y.S., Kim Y., Yoo S.H. Regulation of Inflammation by Sucrose Isomer, Turanose, in Raw 264.7 Cells. J. Cancer Prev. 2017;22:195&#x2013;201. doi: 10.15430/JCP.2017.22.3.195.</Citation><ArticleIdList><ArticleId IdType="doi">10.15430/JCP.2017.22.3.195</ArticleId><ArticleId IdType="pmc">PMC5624461</ArticleId><ArticleId IdType="pubmed">29018785</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahlqvist A. Characterization of three different hog intestinal maltases. Acta Chem. Scand. 1960;14:1&#x2013;8. doi: 10.3891/acta.chem.scand.14-0001.</Citation><ArticleIdList><ArticleId IdType="doi">10.3891/acta.chem.scand.14-0001</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyss M., Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol. Rev. 2000;80:1107&#x2013;1213. doi: 10.1152/physrev.2000.80.3.1107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.2000.80.3.1107</ArticleId><ArticleId IdType="pubmed">10893433</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanna-El-Daher L., Braissant O. Creatine synthesis and exchanges between brain cells: What can be learned from human creatine deficiencies and various experimental models? Amino Acids. 2016;48:1877&#x2013;1895. doi: 10.1007/s00726-016-2189-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-016-2189-0</ArticleId><ArticleId IdType="pubmed">26861125</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito S., Shahbaz S., Luo X., Osman M., Redmond D., Cohen Tervaert J.W., Li L., Elahi S. Metabolomic and immune alterations in long COVID patients with chronic fatigue syndrome. Front. Immunol. 2024;15:1341843. doi: 10.3389/fimmu.2024.1341843.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2024.1341843</ArticleId><ArticleId IdType="pmc">PMC10830702</ArticleId><ArticleId IdType="pubmed">38304426</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Hern&#xe1;ndez Y., Mon&#xe1;rrez-Espino J., L&#xf3;pez D.A.G., Zheng J., Borrego J.C., Torres-Calzada C., Elizalde-D&#xed;az M., Mandal R., Berjanskii M., Mart&#xed;nez-Mart&#xed;nez E., et al. The plasma metabolome of long COVID patients two years after infection. Sci. Rep. 2023;13:12420. doi: 10.1038/s41598-023-39049-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-39049-x</ArticleId><ArticleId IdType="pmc">PMC10394026</ArticleId><ArticleId IdType="pubmed">37528111</ArticleId></ArticleIdList></Reference><Reference><Citation>Berezhnoy G., Bissinger R., Liu A., Cannet C., Sch&#xe4;fer H., Kienzle K., Bitzer M., H&#xe4;berle H., G&#xf6;pel S., Trautwein C., et al. Maintained imbalance of triglycerides, apolipoproteins, energy metabolites and cytokines in long-term COVID-19 syndrome patients. Front. Immunol. 2023;14:1144224. doi: 10.3389/fimmu.2023.1144224.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1144224</ArticleId><ArticleId IdType="pmc">PMC10203989</ArticleId><ArticleId IdType="pubmed">37228606</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Li X., Wu Q., Wang X., Qin Z., Wang Y., He Y., Wu Q., Li L., Chen H. Plasma proteomic and metabolomic characterization of COVID-19 survivors 6 months after discharge. Cell Death Dis. 2022;13:235. doi: 10.1038/s41419-022-04674-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-022-04674-3</ArticleId><ArticleId IdType="pmc">PMC8919172</ArticleId><ArticleId IdType="pubmed">35288537</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer R.A., Brown T.R., Krilowicz B.L., Kushmerick M.J. Phosphagen and intracellular pH changes during contraction of creatine-depleted rat muscle. Am. J. Physiol. 1986;250:C264&#x2013;C274. doi: 10.1152/ajpcell.1986.250.2.C264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.1986.250.2.C264</ArticleId><ArticleId IdType="pubmed">3953780</ArticleId></ArticleIdList></Reference><Reference><Citation>De Benedetto F., Pastorelli R., Ferrario M., de Blasio F., Marinari S., Brunelli L., Wouters E.F.M., Polverino F., Celli B.R., Interdisciplinary Association for Research in Lung Disease (AIMAR) Study Group Supplementation with Qter&#xae; and Creatine improves functional performance in COPD patients on long-term oxygen therapy. Respir. Med. 2018;142:86&#x2013;93. doi: 10.1016/j.rmed.2018.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2018.08.002</ArticleId><ArticleId IdType="pubmed">30170808</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>